Plasma OPN levels were measured in 81 patients with cervical cancer, 34 patients with carcinoma in situ (CIS) of the uterine cervix, and 283 healthy women using enzyme-linked immunosorbent assay (ELISA). This evidence concerns the gene SPP1 and cervical carcinoma.